EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

CLINICAL USEFULNESS OF CREATININE AND CYSTATIN C- AN UPDATE

Fredrick Saron, Dhananjayan R., Swaminathan S.*

ABSTRACT

According to World Health Organization, the number of people affected with kidney failure worldwide is around 10% and annually about one million people die due to untreated kidney disease. The contributing factors for kidney diseases include untreated hypertension and type 2 diabetes mellitus (T2DM). The first line of biomarker to detect kidney failure is the measurement of serum creatinine and the detection of proteins in urine and once both are elevated, the next stage is to measure Creatinine Clearance (Cr-Cl) by using serum and urine creatinine to calculate Glomurelur Filtration Rate (GFR). Recently, Cystatin C (CysC) has emerged as an alternate marker to serum Creatinine (Sr-Cr). The aim of this review article is to bring into focus the merits and demerits of using estimated GFR (eGFR), based on Sr-Cr and CysC values as preliminary to aid clinicians in the diagnosis of Kidney related diseases.

Keywords: Cystatin C, Creatinine, Glomerular Filtration Rate, eGFR, Cr-Cl.

[Full Text Article] [Download Certificate]